Cardinal Health Inc. (CAH Quick QuoteCAH - Free Report) is a healthcare services company engaged in providing pharmaceutical and medical products and services in the United States and International markets. The company primarily operates in two segments, Pharmaceutical and Medical.

Currently, Cardinal Health has a Zacks Rank #4 (Sell) but that could change following its fourth-quarter fiscal 2016 earnings report which has just released. We have highlighted some of the key details from the just-released announcement below:

Earnings: Cardinal Health’s adjusted earnings surged 14% on a year-over-year basis to $1.14 per share. It also managed to outpace the Zacks Consensus Estimate of $1.13.

Revenues: Revenues increased 14% on a year-over-year basis to $31.38 billion. It also managed to beat the Zacks Consensus Estimate of $30.67 billion.
 

Key Stats: Pharmaceutical revenues surged 14% to $28.18 billion while revenues from Medical segment increased 12% to $3.21 billion in the quarter.

Major Factors: Pharmaceutical segment revenues increased due to strong growth from existing and net new distribution customers. Strong performance from the Specialty business also drove results. Higher contributions from acquisitions and strong growth from Cardinal Health brand products were primarily responsible for the growth in Medical segment revenues.

Stock Price: Following the earnings release, share prices did not show any movement in the pre-market trading session.

Check back later for our full write up on this Cardinal Health earnings report later!   

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>